the Grifols Erytra Eflexis® installed in the hospital Rivierenland @ Tiel, Netherlands!
We are very excited to announce that the next Grifols Erytra Eflexis® bloodgroup analyser just went live in the laboratories of the hospital Rivierenl...
We are very excited to announce that the next Grifols Erytra Eflexis® bloodgroup analyser just went live in the laboratories of the hospital Rivierenl...
In Flanders and the Netherlands, Grifols Erytra Eflexis was already a big success. But also at Wallonia they discovered the added value of the Eflexis...
This week they installed the Grifols Erytra Eflexis analyser at CHC Liège. ( Clinique CHC MontLégia) apDia is committed to provide customers with inno...
Thursday March 31rd, 2022 (10:30 – 16:00) Our goal is to exchange experiences with the MAIPA technology and platelet serology in general and to...
Qualitative detection and differentiation of Influenza A/B (M gene/NP1 gene) and SARS-CoV-2 (E gene; RdRp gene) respiratory sample material. Reliable:...
Also during the COVID-19 pandemic, the technical people from apDia keep on working very hard, taking into account all safety regulations. This week, t...
Therapeutic drug monitoring (TDM) plays a significant role in clinical decision-making and is rapidly becoming an essential and specialized element of...
After the successes in Belgium. apDia installed the first Grifols Eflexis blood group analysers in the laboratories at the Netherlands. The Erytra Efl...
In a report from the National Institute of Public Health and the Environment in the Netherlands , R-biopharm’s RIDA®GENE SARS-CoV-2 RT-PCR kit,...
Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.
63739 street lorem ipsum City, Country
+12 (0) 345 678 9
info@company.com